{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:15:45Z","timestamp":1792289745299,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,10]]},"DOI":"10.7759\/cureus.27847","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T13:01:02Z","timestamp":1660136462000},"source":"Crossref","is-referenced-by-count":6,"title":["Renal Function in Hypertensive Patients Receiving Cilnidipine and L-Type Calcium Channel Blockers: A Meta-Analysis of Randomized Controlled and Retrospective Studies"],"prefix":"10.7759","author":[{"given":"Mayakalyani","family":"Srivathsan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Vardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayali","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepakkumar G","family":"Langade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124123","article-title":"Renal denervation suppresses atrial fibrillation in a model of renal impairment","volume":"10","author":"Liang Z","year":"2015","unstructured":"Liang Z, Shi XM, Liu LF, et al.. Renal denervation suppresses atrial fibrillation in a model of renal impairment. PLoS One. 2015, 10:e0124123. 10.1371\/journal.pone.0124123","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease","volume":"106","author":"Hausberg M","year":"2002","unstructured":"Hausberg M, Kosch M, Harmelink P, et al.. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002, 106:1974-1979. 10.1161\/01.cir.0000034043.16664.96","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701342","article-title":"Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones","volume":"122","author":"Uneyama H","year":"1997","unstructured":"Uneyama H, Takahara A, Dohmoto H, Yoshimoto R, Inoue K, Akaike N. Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br J Pharmacol. 1997, 122:37-42. 10.1038\/sj.bjp.0701342","journal-title":"Br J Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00407.x","article-title":"Long-term blockade of L\/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart","volume":"158","author":"Takahara A","year":"2009","unstructured":"Takahara A, Nakamura Y, Wagatsuma H, et al.. Long-term blockade of L\/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. Br J Pharmacol. 2009, 158:1366-1374. 10.1111\/j.1476-5381.2009.00407.x","journal-title":"Br J Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.379","article-title":"Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases","volume":"27","author":"Kojima S","year":"2004","unstructured":"Kojima S, Shida M, Yokoyama H. Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases. Hypertens Res. 2004, 27:379-385. 10.1291\/hypres.27.379","journal-title":"Hypertens Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002623","article-title":"Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease","volume":"72","author":"Fujita T","year":"2007","unstructured":"Fujita T, Ando K, Nishimura H, Ideura T, Yasuda G, Isshiki M, Takahashi K. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int. 2007, 72:1543-1549. 10.1038\/sj.ki.5002623","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282c2fa62","article-title":"Renal and vascular protective effects of cilnidipine in patients with essential hypertension","volume":"25","author":"Morimoto S","year":"2007","unstructured":"Morimoto S, Yano Y, Maki K, Iwasaka T. Renal and vascular protective effects of cilnidipine in patients with essential hypertension. J Hypertens. 2007, 25:2178-2183. 10.1097\/HJH.0b013e3282c2fa62","journal-title":"J Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/1874241600902010031","article-title":"Change of glomerular hemodynamics in patients with advanced chronic kidney disease after cilnidipine therapy","volume":"2","author":"Satomura A","year":"2009","unstructured":"Satomura A, Fujita T, Fuke Y, Wada Y, Matsumoto K. Change of glomerular hemodynamics in patients with advanced chronic kidney disease after cilnidipine therapy. Open Clin Chem J. 2009, 2:31-36. 10.2174\/1874241600902010031","journal-title":"Open Clin Chem J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833d01dd","article-title":"A new-generation N\/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker","volume":"28","author":"Konoshita T","year":"2010","unstructured":"Konoshita T, Makino Y, Kimura T, et al.. A new-generation N\/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker. J Hypertens. 2010, 28:2156-2160. 10.1097\/HJH.0b013e32833d01dd","journal-title":"J Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/10641961003667914","article-title":"Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection","volume":"32","author":"Miwa Y","year":"2010","unstructured":"Miwa Y, Tsuchihashi T, Ohta Y, et al.. Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection. Clin Exp Hypertens. 2010, 32:400-405. 10.3109\/10641961003667914","journal-title":"Clin Exp Hypertens"},{"key":"ref11","article-title":"Cilnidipine and felodipine in essential hypertension with type-2 diabetes and renal damage","volume":"5","author":"Cao BQ","year":"2010","unstructured":"Cao BQ , Liu DY, Wang SZ, et al.. Cilnidipine and felodipine in essential hypertension with type-2 diabetes and renal damage. China Med. 2010, 5:494-496.","journal-title":"China Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.5508","article-title":"Comparison of the antialbuminuric effects of L-\/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial","volume":"10","author":"Ando K","year":"2013","unstructured":"Ando K, Ueshima K, Tanaka S, et al.. Comparison of the antialbuminuric effects of L-\/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial. Int J Med Sci. 2013, 10:1209-1216. 10.7150\/ijms.5508","journal-title":"Int J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-012-0274-1","article-title":"L\/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease","volume":"28","author":"Abe M","year":"2013","unstructured":"Abe M, Maruyama N, Suzuki H, Inoshita A, Yoshida Y, Okada K, Soma M. L\/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease. Heart Vessels. 2013, 28:480-489. 10.1007\/s00380-012-0274-1","journal-title":"Heart Vessels"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140816866","article-title":"L\/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease","volume":"14","author":"Kanaoka T","year":"2013","unstructured":"Kanaoka T, Tamura K, Wakui H, et al.. L\/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease. Int J Mol Sci. 2013, 14:16866-16881. 10.3390\/ijms140816866","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.24304\/kjcp.2020.30.4.259","article-title":"Comparison of usage patterns and outcomes by dual type calcium channel blockers in patients with chronic kidney disease","volume":"30","author":"Oh MR","year":"2020","unstructured":"Oh MR, Ahn HL, Choi S, La HO. Comparison of usage patterns and outcomes by dual type calcium channel blockers in patients with chronic kidney disease. Korean J Clin Pharm. 2020, 30:259-263. 10.24304\/kjcp.2020.30.4.259","journal-title":"Korean J Clin Pharm"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/1573402110666140131155331","article-title":"L-\/N-type calcium channel blockers and proteinuria","volume":"9","author":"Ando K","year":"2013","unstructured":"Ando K. L-\/N-type calcium channel blockers and proteinuria. Curr Hypertens Rev. 2013, 9:210-218. 10.2174\/1573402110666140131155331","journal-title":"Curr Hypertens Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.279","article-title":"L\/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats","volume":"34","author":"Toba H","year":"2011","unstructured":"Toba H, Yoshida M, Tojo C, et al.. L\/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Hypertens Res. 2011, 34:521-529. 10.1038\/hr.2010.279","journal-title":"Hypertens Res"},{"key":"ref18","article-title":"Evaluation of glomerular filtration rate and of albuminuria\/proteinuria","volume":"23","author":"Cirillo M","year":"2010","unstructured":"Cirillo M. Evaluation of glomerular filtration rate and of albuminuria\/proteinuria. J Nephrol. 2010, 23:125-132.","journal-title":"J Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-0821-9","article-title":"Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review","volume":"19","author":"Norris KC","year":"2018","unstructured":"Norris KC, Smoyer KE, Rolland C, Van der Vaart J, Grubb EB. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018, 19:36. 10.1186\/s12882-018-0821-9","journal-title":"BMC Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5246\/jcps.2015.11.095","article-title":"Effects of cilnidipine and L-type calcium channel blockers on renal functions in hypertensive patients: a meta-analysis of the randomized trials","volume":"24","author":"Yei X","year":"2015","unstructured":"Yei X, Dong Z, Zhao C, et al.. Effects of cilnidipine and L-type calcium channel blockers on renal functions in hypertensive patients: a meta-analysis of the randomized trials. J Chinese Pharm Sci. 2015, 24:10.5246\/jcps.2015.11.095","journal-title":"J Chinese Pharm Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease","volume":"79","author":"Pugh D","year":"2019","unstructured":"Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019, 79:365-379. 10.1007\/s40265-019-1064-1","journal-title":"Drugs"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2009.00079.x","article-title":"Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release","volume":"27","author":"Takahara A","year":"2009","unstructured":"Takahara A. Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release. Cardiovasc Ther. 2009, 27:124-139. 10.1111\/j.1755-5922.2009.00079.x","journal-title":"Cardiovasc Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109478-renal-function-in-hypertensive-patients-receiving-cilnidipine-and-l-type-calcium-channel-blockers-a-meta-analysis-of-randomized-controlled-and-retrospective-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:55Z","timestamp":1707507415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109478-renal-function-in-hypertensive-patients-receiving-cilnidipine-and-l-type-calcium-channel-blockers-a-meta-analysis-of-randomized-controlled-and-retrospective-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.27847","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,10]]}}}